Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15904
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gemphire Therapeutics Inc (GEMP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead product Gemcabene (CI-1027), which is licensed from Pfizer is an oral therapy that targets known lipid metabolic pathways, lowering levels of LDL-C, inflammation and triglycerides. The company is evaluating gemcabene in clinical trials to enhance the clearance of very low-density lipoproteins (VLDLs) and to and inhibit the production of fatty acids and cholesterol in the liver. Gemphire is headquartered in Livonia, Michigan, the US.

Gemphire Therapeutics Inc Key Recent Developments

Mar 15,2019 Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13,2018 Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08,2018 Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03,2018 Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gemphire Therapeutics Inc – Key Facts
Gemphire Therapeutics Inc – Key Employees
Gemphire Therapeutics Inc – Key Employee Biographies
Gemphire Therapeutics Inc – Major Products and Services
Gemphire Therapeutics Inc – History
Gemphire Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Gemphire Therapeutics Inc – Business Description
Gemphire Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Gemphire Therapeutics Inc – Strengths
Gemphire Therapeutics Inc – Weaknesses
Gemphire Therapeutics Inc – Opportunities
Gemphire Therapeutics Inc – Threats
Gemphire Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2019: Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13, 2018: Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08, 2018: Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03, 2018: Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
Mar 15, 2018: Gemphire Therapeutics Announces Fourth Quarter And Fiscal Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gemphire Therapeutics Inc, Key Facts
Gemphire Therapeutics Inc, Key Employees
Gemphire Therapeutics Inc, Key Employee Biographies
Gemphire Therapeutics Inc, Major Products and Services
Gemphire Therapeutics Inc, History
Gemphire Therapeutics Inc, Key Competitors
Gemphire Therapeutics Inc, Ratios based on current share price
Gemphire Therapeutics Inc, Annual Ratios
Gemphire Therapeutics Inc, Annual Ratios (Cont...1)
Gemphire Therapeutics Inc, Interim Ratios
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gemphire Therapeutics Inc, Performance Chart (2014 - 2018)
Gemphire Therapeutics Inc, Ratio Charts
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • E-Shelter Facility Service Gmbh:企業の戦略・SWOT・財務分析
    SummaryE-Shelter Facility Service Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Targa Resources Partners LP (NGLS PR A)-エネルギー分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Staatsolie Maatschappij Suriname N.V.:企業のM&A・提携動向(石油・ガス分野)
    Summary Staatsolie Maatschappij Suriname N.V. (Staatsolie) is a state-owned integrated energy company. It operates as a commercial entity and performs institutional functions. Commercially, the company carries out exploration, drilling, production and treatment; refining of crude oil; transportation …
  • Larsen & Toubro Limited:企業のM&A・提携・投資分析
    Larsen & Toubro Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Larsen & Toubro Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Coventry Building Society:企業の戦略・SWOT・財務分析
    SummaryCoventry Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • India Gelatine & Chemicals Ltd. (531253):企業財務及び戦略的SWOT分析
    Summary India Gelatine & Chemicals Ltd. (IGCL) is a chemical company that provides manufacturing and marketing of nutritional products. The company offers products such as edible gelatin, photographic gelatin, technical gelatin and pharmaceutical gelatin. Its gelatin provides odorless and tasteless …
  • TransDigm Group Incorporated:企業概要、SWOT及び財務分析
    Product Synopsis SDI's "TransDigm Group Incorporated : Aerospace and Defense - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busi …
  • OJSC “Surgutneftegas”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OJSC "Surgutneftegas" Mergers a …
  • OncoTherapy Science Inc (4564):医療機器:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Meyer Burger (Germany) AG (R8R):企業のM&A・提携動向(エネルギー分野)
    Summary Meyer Burger (Germany) AG (Meyer Burger), formerly Roth & Rau AG is a subsidiary of Meyer Burger Technology AG is a photovoltaic equipment company that provides technologies and manufacturing equipment for the coating of surfaces. The company’s products include photovoltaic, plasma and ion b …
  • Mulpha International Bhd (MULPHA):企業概要、財務及び戦略的SWOT分析
    Summary Mulpha International Bhd (Mulpha) is a property development company. The company’s activities include property development and investment, infrastructure and civil construction. Its projects include Seberang Prai within the Northern Corridor Economic Region, and the gated resort development …
  • Trafigura Beheer B.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Trafigura Beheer B.V. Mergers a …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    SummaryThaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Energy & Exploration Partners, LLC:企業のM&A・提携動向(石油・ガス分野)
    Summary Energy & Exploration Partners, LLC (ENXP) is an oil and gas company that offers exploration and development, and oil resource explorations. The company acquires, explores, produces and develops unconventional oil and natural gas resources and assets. Its exploration activities include multi- …
  • Syneron Medical Ltd-医療機器分野:企業M&A・提携分析
    Summary Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of …
  • Aesculap, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Aesculap, Inc. (Aesculap) is a medical device company that designs, manufactures, and distributes medical implants, surgical implants, and other related devices. The company’s products include neurosurgery products, power systems, sterile processing products, surgical instruments, and wound …
  • Accruent, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Accruent, LLC Mergers and Acqui …
  • Ana Holdings Inc.:戦略・SWOT・企業財務分析
    Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Unisplendour Guhan Group Corporation Ltd (000590):企業の財務及び戦略的SWOT分析
    Summary Unisplendour Guhan Group Corporation Limited (Unisplendour) is a pharmaceutical company that manufactures and markets traditional Chinese medicine remedies, prescription, medicine agents and biological products. The company offers Chinese medicines and Chinese healthcare products for cold tr …
  • Constellation Energy Partners LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Constellation Energy Partners L …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆